| JXSL2101030 | 泽弗利单抗注射液 | zalifrelimab | Injection | Biological Products(1) | Import Drug Application | 2021-05-20 | | Betta Pharmaceuticals Co Ltd | | | view |
| JXSL2101016 | 巴替利单抗注射液 | balstilimab | Injection | Biological Products(1) | Import Drug Application | 2021-05-13 | | Betta Pharmaceuticals Co Ltd | | | view |
| JXSL2101015 | 泽弗利单抗注射液 | zalifrelimab | Injection | Biological Products(1) | Import Drug Application | 2021-04-27 | | Betta Pharmaceuticals Co Ltd | | | view |
| CYZB1606479 | 烧伤止痛膏 | | Ointment | Chinese Herbal Medicine | Supplementary Application | 2016-10-13 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2018-07-24 | view |
| CYZB0807357 | 烧伤止痛膏 | | Ointment | Chinese Herbal Medicine | Supplementary Application | 2008-10-17 | 浙江贝达药业有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2009-04-24 | view |
| CYHS1400149 | 阿托伐他汀钙片 | atorvastatin calcium | Tablet | Chemical Drugs(6) | Generic Drug | 2014-07-24 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2016-02-04 | view |
| CYHS1290046 | 苯磺酸氨氯地平片 | amlodipine besylate | Tablet | Chemical Drugs(6) | Generic Drug | 2012-04-26 | 浙江贝达药业有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2016-03-10 | view |
| CYHS1200795 | 缬沙坦胶囊 | valsartan | Capsule | Chemical Drugs(6) | Generic Drug | 2013-04-28 | 浙江贝达药业有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2015-12-24 | view |
| CYHS0900872 | 苯磺酸氨氯地平片 | amlodipine besylate | Tablet | Chemical Drugs(6) | Generic Drug | 2009-12-07 | 浙江贝达药业有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2011-01-11 | view |
| CYHB2101570 | 盐酸恩沙替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-07-13 | | Betta Pharmaceuticals Co Ltd | | | view |
| CYHB2101569 | 盐酸恩沙替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-07-13 | | Betta Pharmaceuticals Co Ltd | | | view |
| CYHB1402346 | 盐酸埃克替尼片 | Icotinib | Tablet | Chemical Drugs | Supplementary Application | 2014-04-28 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2014-12-25 | view |
| CYHB1311153 | 盐酸埃克替尼片 | Icotinib | Tablet | Chemical Drugs | Supplementary Application | 2014-01-15 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2014-11-21 | view |
| CXSL2400603 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2024-09-11 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXSL2300322 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2023-05-09 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXSL2200622 | BPB-101双抗注射液 | BPB-101 | Injection | Biological Products(1) | New Drug Application | 2022-12-29 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXSL2100011 | MCLA-129注射液 | MCLA-129 | Injection | Biological Products(1) | New Drug Application | 2021-01-09 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2021-01-08 | view |
| CXSB2200001 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | Supplementary Application | 2022-01-07 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHS2400039 | 酒石酸泰贝西利胶囊 | BPI-16350 | Capsule | Chemical Drugs(1) | New Drug Application | 2024-05-01 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHS2300016 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2023-01-20 | | Betta Pharmaceuticals Co Ltd | | | view |
